Effect of Privigen Against Graft Loss

NCT02374736 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Privigen (Human normal immunoglobulin G (IgG > 98 % purity))

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]